Research Digest

Lab notes: New method to tinker cell surface proteins can help design new drugs

Drug companies are investing heavily to identify new drug molecules that can target these key proteins.

A group of Indian scientists have found a new way to modulate specific cellular functions by tinkering with proteins that play a role in cells’ response to external chemicals like drugs.

The new finding, described in a paper published last week in journal Nature Nanotechnology, makes it convenient for researchers to study the workings of a large family of sensor proteins called G-protein-coupled receptors or GPCRs and to develop potential synthetic antibody-based drugs.

Research teams led by Dr Arun K Shukla at the Indian Institute of Technology, Kanpur have engineered synthetic antibody fragments that target beta-arrestin – a class of proteins inside the cell. GPCRs are mobile proteins that sit in the cell membranes and support cells to respond to chemical signals from body parts or external world. GPCRs are the most sought-after drug targets in modern medical research. Drug companies are investing heavily to identify new drug molecules that can target key GPCRs involved in several pathophysiological conditions. Beta-arrestin regulates actions of GPCRs by attenuating its signaling.

“There are more than 800 GPCRs and only limited beta-arrestin which controls its functioning, therefore, targeting beta-arrestin will enable us with a greater handle over the desired signaling across all GPCR types. So, we developed synthetic Fabs (fragment antigen-binding) that targets beta-arrestin and have potential to modulate their functioning,” explained Shukla.

Arun K Shukla with members of his research team.
Arun K Shukla with members of his research team.

According to the study, small molecule-based drugs, which either bind to stimulate or inhibit GPCR, remains a traditional way of tweaking the GPCRs. Shukla says that beta-arrestin functions are usually studied by either knocking the gene out or turning their expression down by silencing of protein coding genes. But synthetic Fab molecules can specifically target a particular part of the protein and selectively offset its function without interfering with its any other function, attributed to its other domains. “Our finding is the first demonstration of targeting a specific function of beta-arrestins without altering its other functions,” said Eshan Ghosh, first author of this paper.

This study was an ambitious project to design a generic tool to study GPCRs. “Initially, in vitro studies, we found very encouraging results but the real deal was to replicate the study in cellular systems, where we can really see the molecule in action by monitoring its cellular readouts,” said Shukla. Interestingly, during microscopic experiments, Shukla’s team members could observe that this Fab in form of an intrabody (an antibody that works within the cell) was clearly blocking the endocytosis (pulling in of a GPCR from the surface to inside of a living cell).

“The synthetic intrabody we have identified has the potential to treat many diseases implicating GPCRs if its delivery vehicle is well devised,” said Mithu Baidya, one of the authors of this study.

“Our approach has the potential to take antibody-based drug discovery to the next level, where we can dissect to compartmentalise the functioning of a protein and thereby modulate it. This study will flag off a new direction for future drug discovery,” said the study leader.

Research team included Eshan Ghosh, Ashish Srivastava, Mithu Baidya, Punita Kumari, Hemlata Dwivedi, Kumari Nidhi, Ravi Ranjan and Arun K Shukla from the Indian Institute of Technology, Kanpur, Shalini Dogra, Prem N Yadav from CSIR-Central Drug Research Institute, Lucknow, Akiko Koide, Shohei Koide from Laura and Isaac Perlmutter Cancer Center, USA, and Sachdev S Sidhu from the University of Toronto, Canada.

This article was first published by India Science Wire.

We welcome your comments at letters@scroll.in.
Sponsored Content BY 

Watch Ruchir's journey: A story that captures the impact of accessible technology

Accessible technology has the potential to change lives.

“Technology can be a great leveller”, affirms Ruchir Falodia, Social Media Manager, TATA CLiQ. Out of the many qualities that define Ruchir as a person, one that stands out is that he is an autodidact – a self-taught coder and lover of technology.

Ruchir’s story is one that humanises technology - it has always played the role of a supportive friend who would look beyond his visual impairment. A top ranker through school and college, Ruchir would scan course books and convert them to a format which could be read out to him (in the absence of e-books for school). He also developed a lot of his work ethos on the philosophy of Open Source software, having contributed to various open source projects. The access provided by Open Source, where users could take a source code, modify it and distribute their own versions of the program, attracted him because of the even footing it gave everyone.

That is why I like being in programming. Nobody cares if you are in a wheelchair. Whatever be your physical disability, you are equal with every other developer. If your code works, good. If it doesn’t, you’ll be told so.

— Ruchir.

Motivated by the objectivity that technology provided, Ruchir made it his career. Despite having earned degree in computer engineering and an MBA, friends and family feared his visual impairment would prove difficult to overcome in a work setting. But Ruchir, who doesn’t like quotas or the ‘special’ tag he is often labelled with, used technology to prove that differently abled persons can work on an equal footing.

As he delved deeper into the tech space, Ruchir realised that he sought to explore the human side of technology. A fan of Agatha Christie and other crime novels, he wanted to express himself through storytelling and steered his career towards branding and marketing – which he sees as another way to tell stories.

Ruchir, then, migrated to Mumbai for the next phase in his career. It was in the Maximum City that his belief in technology being the great leveller was reinforced. “The city’s infrastructure is a challenging one, Uber helped me navigate the city” says Ruchir. By using the VoiceOver features, Ruchir could call an Uber wherever he was and move around easily. He reached out to Uber to see if together they could spread the message of accessible technology. This partnership resulted in a video that captures the essence of Ruchir’s story: The World in Voices.

Play

It was important for Ruchir to get rid of the sympathetic lens through which others saw him. His story serves as a message of reassurance to other differently abled persons and abolishes some of the fears, doubts and prejudices present in families, friends, employers or colleagues.

To know more about Ruchir’s journey, see here.

This article was produced by the Scroll marketing team on behalf of Uber and not by the Scroll editorial team.